AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -68.6% | 15,482 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -22.2% | 15,482 | 0.0% | 0.00% | – |
| Q3 2021 | $45,000 | -23.7% | 15,482 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | +13.5% | 15,482 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +20.9% | 15,482 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | +10.3% | 15,482 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -81.4% | 15,482 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $210,000 | +377.3% | 15,482 | +167.9% | 0.00% | – |
| Q1 2020 | $44,000 | +18.9% | 5,779 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | +60.9% | 5,779 | 0.0% | 0.00% | – |
| Q3 2019 | $23,000 | -17.9% | 5,779 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | -40.4% | 5,779 | 0.0% | 0.00% | – |
| Q1 2019 | $47,000 | +9.3% | 5,779 | -26.0% | 0.00% | – |
| Q4 2018 | $43,000 | -2.3% | 7,812 | +57.0% | 0.00% | – |
| Q3 2018 | $44,000 | -12.0% | 4,977 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | +150.0% | 4,977 | +136.9% | 0.00% | – |
| Q1 2018 | $20,000 | – | 2,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |